91 related articles for article (PubMed ID: 7665927)
1. Study of interleukin-2 receptor in schistosomiasis mansoni and its analogous changes in collagen diseases and schistosomal arthropathy.
Khalil HM; el Missiry AG; Fahmy HM; Khalil NM; Nadia ; Sabry M; Abdel Atty HE; Tamara FA; Amer N; el Baz HG
J Egypt Soc Parasitol; 1995 Aug; 25(2):289-302. PubMed ID: 7665927
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of tumour necrosis factor- alpha in schistosomiasis mansoni and their analogous changes in collagen diseases and schistosomal arthropathy.
Khalil HM; el-Missiry AG; Abdalla HM; Khalil NM; Sabry NM; Abdel-Atty HE; Tamara FA; el-Tayeb M; Zakaria NM
J Egypt Soc Parasitol; 1995 Aug; 25(2):427-36. PubMed ID: 7665938
[TBL] [Abstract][Full Text] [Related]
3. Study of gamma-interferon in schistosomiasis mansoni, autoimmune diseases and schistosomal arthropathy.
Abdel-Aaty HE; Selim MM; Abdel-Rehim HA
J Egypt Soc Parasitol; 1999; 29(3):721-34. PubMed ID: 12561913
[TBL] [Abstract][Full Text] [Related]
4. [Serum soluble interleukin 2 receptor levels in patients with diffuse connective tissue diseases].
Sun HY; Liu WL; Xiu HZ
Zhonghua Nei Ke Za Zhi; 1993 Aug; 32(8):528-30. PubMed ID: 8269781
[TBL] [Abstract][Full Text] [Related]
5. [The clinical significance of the measurement of serum soluble interleukin-2 receptors in various diseases].
Sugimoto H; Hashimoto N; Suzuki S; Gejyo F
Rinsho Byori; 1996 Feb; 44(2):176-82. PubMed ID: 8851203
[TBL] [Abstract][Full Text] [Related]
6. Impaired urinary excretion of soluble IL-2 receptors in patients with systemic lupus erythematosus and rheumatoid arthritis.
Manoussakis MN; Germanidis GS; Drosos AA; Moutsopoulos HM
Lupus; 1992 Feb; 1(2):105-9. PubMed ID: 1301961
[TBL] [Abstract][Full Text] [Related]
7. Pleural fluid soluble interleukin 2 receptor in rheumatoid arthritis and systemic lupus erythematosus.
Pettersson T; Söderblom T; Nyberg P; Riska H; Linko L; Klockars M
J Rheumatol; 1994 Oct; 21(10):1820-4. PubMed ID: 7837144
[TBL] [Abstract][Full Text] [Related]
8. Serum soluble interleukin-2 receptor, soluble CD8 and soluble intercellular adhesion molecule-1 levels in Crohn's disease, celiac disease, and systemic lupus erythematosus.
Srivastava MD; Rossi TM; Lebenthal E
Res Commun Mol Pathol Pharmacol; 1995 Jan; 87(1):21-6. PubMed ID: 7735726
[TBL] [Abstract][Full Text] [Related]
9. Soluble interleukin 2 receptor levels in serum and its relationship to T cell abnormality and clinical manifestations of the disease in patients with systemic lupus erythematosus.
Raziuddin S; al-Janadi MA; al-Wabel AA
J Rheumatol; 1991 Jun; 18(6):831-6. PubMed ID: 1680190
[TBL] [Abstract][Full Text] [Related]
10. Serum interleukin-2 receptor in systemic lupus erythematosus and rheumatoid arthritis.
Lee GL; Chen MY; Chuang CY; Chen CY
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1988 Feb; 21(1):16-22. PubMed ID: 3264781
[TBL] [Abstract][Full Text] [Related]
11. Soluble interleukin-2 receptor in juvenile rheumatoid arthritis.
Silverman ED; Laxer RM; Nelson DL; Rubin LA
J Rheumatol; 1991 Sep; 18(9):1398-402. PubMed ID: 1757944
[TBL] [Abstract][Full Text] [Related]
12. The effects of nonsteroidal antiinflammatory drug therapy in early rheumatoid arthritis on serum levels of soluble interleukin 2 receptor, CD4, and CD8.
Dooley MA; Cush JJ; Lipsky PE; Dawson DV; Pisetsky DS
J Rheumatol; 1993 Nov; 20(11):1857-62. PubMed ID: 8308770
[TBL] [Abstract][Full Text] [Related]
13. Serum soluble IL-2 receptor as a marker of lymphocyte activation in some autoimmune diseases. Effect of immunosuppressive therapy.
Dejica D
Roum Arch Microbiol Immunol; 2001; 60(3):183-201. PubMed ID: 12165973
[TBL] [Abstract][Full Text] [Related]
14. Interleukin 2 receptor in patients with localized and systemic parasitic diseases.
Josimovic-Alasevic O; Feldmeier H; Zwingenberger K; Harms G; Hahn H; Shrisuphanunt M; Diamantstein T
Clin Exp Immunol; 1988 May; 72(2):249-54. PubMed ID: 3136958
[TBL] [Abstract][Full Text] [Related]
15. Soluble interleukin-6 receptor in plasma and in lymphocyte culture supernatants of healthy individuals and patients with systemic lupus erythematosus and rheumatoid arthritis.
Polgár A; Brózik M; Tóth S; Holub M; Hegyi K; Kádár A; Hodinka L; Falus A
Med Sci Monit; 2000; 6(1):13-8. PubMed ID: 11208277
[TBL] [Abstract][Full Text] [Related]
16. [The changes of T lymphocyte subsets and serum interleukin-2 receptor in peripheral blood of the pregnant women complicated by systemic lupus erythematosus].
Su Y; Hong S; Zhao A
Zhonghua Fu Chan Ke Za Zhi; 1997 Nov; 32(11):671-3. PubMed ID: 9639769
[TBL] [Abstract][Full Text] [Related]
17. [The significance of soluble IL-2 receptors in rheumatoid arthritis with interstitial pneumonia].
Tada S; Namba J; Yokota S; Sugimoto K; Imajo K; Kawabata H; Irie S; Kimura I; Kitani H; Tanizaki K
Arerugi; 1992 Mar; 41(3):428-33. PubMed ID: 1575640
[TBL] [Abstract][Full Text] [Related]
18. Anti-citrullinated peptide antibodies in lupus patients with or without deforming arthropathy.
Damián-Abrego GN; Cabiedes J; Cabral AR
Lupus; 2008 Apr; 17(4):300-4. PubMed ID: 18413411
[TBL] [Abstract][Full Text] [Related]
19. The relationship between soluble interleukin 2 receptor levels and antidouble stranded DNA antibody levels in patients with systemic lupus erythematosus.
Ward MM; Dooley MA; Christenson VD; Pisetsky DS
J Rheumatol; 1991 Feb; 18(2):235-40. PubMed ID: 2023217
[TBL] [Abstract][Full Text] [Related]
20. Serum soluble interleukin 7 receptor is strongly associated with lupus nephritis in patients with systemic lupus erythematosus.
Badot V; Luijten RK; van Roon JA; Depresseux G; Aydin S; Van den Eynde BJ; Houssiau FA; Lauwerys BR
Ann Rheum Dis; 2013 Mar; 72(3):453-6. PubMed ID: 23264357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
